Profile of:
Cristina Fernandez-Carballido
Full name: Cristina Fernandez-Carballido
Current country: Spain
Membership level: Full
Type of membership: Member
Number of publications: 45
Treatment Failure in Axial Spondyloarthritis: Insights for a Standardized Definition (2022)
https://pubmed.ncbi.nlm.nih.gov/35201604/
Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/35898516/
Disease control in patients with psoriatic arthritis in real clinical practice in Spain: MiDAS Study. (2022)
https://doi.org/10.1016/j.reuma.2022.03.006
Disease control in patients with ankylosing spondylitis in real clinical practice in Spain: Results of the MIDAS study. (2022)
https://doi.org/10.1016/j.reuma.2022.01.004
Strategies and resources to optimise the management of Psoriatic Arthritis patients: The CREA Project (2022)
https://pubmed.ncbi.nlm.nih.gov/36068162/
Resources and strategies for the optimal care of patients with axial spondyloarthritis: The CREA project (2022)
https://pubmed.ncbi.nlm.nih.gov/36064886/
Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients (2022)
https://pubmed.ncbi.nlm.nih.gov/35689912/
Cardiovascular and disease-related features associated with extra-articular manifestations in axial spondyloarthritis. A multicenter study of 888 patients. (2022)
https://pubmed.ncbi.nlm.nih.gov/36150319/
Female gender and age are associated to unfavorable response to TNFα inhibitors in patients with axial Spondyloarthritis: results of statistical and artificial intelligence- based data analyses of a national multicentric prospective registry. (2022)
https://pubmed.ncbi.nlm.nih.gov/36278846/
Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients (2021)
https://pubmed.ncbi.nlm.nih.gov/33607385/
Potential relation of cardiovascular risk factors to disease activity in patients with axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34377161/
Remission in axial spondyloarthritis: Developing a consensus definition (2021)
https://pubmed.ncbi.nlm.nih.gov/34301380/
Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study (2021)
https://pubmed.ncbi.nlm.nih.gov/33849644/
Psoriatic arthritis screening: A systematic literature review and experts’ recommendations (2021)
https://pubmed.ncbi.nlm.nih.gov/33720981/
Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study-results at 5 years of follow-up (2021)
https://pubmed.ncbi.nlm.nih.gov/33254222/
Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/32541676/
No radiographic sacroiliitis progression was observed in patients with early spondyloarthritis at 6 years: results of the Esperanza multicentric prospective cohort (2020)
https://pubmed.ncbi.nlm.nih.gov/32907882/
Role of Carotid Ultrasound and Systematic Coronary Risk Evaluation Charts for the Cardiovascular Risk Stratification of Patients with Psoriatic Arthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/31203214/
Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross-Sectional Study (2020)
https://pubmed.ncbi.nlm.nih.gov/31033231/
Magnetic resonance imaging assessment in patients with axial spondyloarthritis: development of checklists for use in clinical practice (2019)
https://pubmed.ncbi.nlm.nih.gov/31535169/
